About Consort Medical
Consort Medical is a Healthcare company based in Hemel Hempstead (United Kingdom) founded in 1946, and was acquired by Recipharm in November 2019. Portfolio of products for airway management and drug delivery. The company has 12 employees. Consort Medical has completed 1 acquisition, including Aesica. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is CONSORT MEDICAL LIMITED.
Company details
Consort Medical is a healthcare company that through its subsidiaries is focused on medical device technologies for drug delivery and hospital products for the management of patient airways. Aesica Pharmaceuticals and Bespak are subsidiaries of Consort Medical. Aesica is a pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services. Bespak is a company active in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.
- Headquarters Hemel Hempstead, United Kingdom
- Employees 12
- Stage Acquired
- SectorsHealthcare
- Website consortmedical.com
- Social LinkedIn X
- Acquired by Recipharm (Nov 2019)
- Legal Name Consort Medical Limited
- Date of Incorporation 22 Mar, 1946
- Jurisdiction KING'S LYNN, NORFOLK, ENGLAND
Investors in Consort Medical
Consort Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Recipharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical development and manufacturing services are offered contractually. | 1995 | recipharm.com | Jordbro, Sweden |
Investor details for Consort Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Consort Medical
Consort Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aesica.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms | aesica-pharma.com | Newcastle Upon Tyne, United Kingdom | 2004 | Sep 2014 | $364.82M |
Complete acquisition details for Consort Medical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Consort Medical
Complete news archive for Consort Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Consort Medical
Consort Medical was founded in 1946.
Consort Medical is headquartered in Hemel Hempstead, United Kingdom.
Consort Medical has 12 employees.
Annual revenue of Consort Medical is $415.33M as on Dec 31, 2018.
Consort Medical is a healthcare company that through its subsidiaries is focused on medical device technologies for drug delivery and hospital products for the management of patient airways. Aesica Pharmaceuticals and Bespak are subsidiaries of Consort Medical. Aesica is a pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services. Bespak is a company active in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.
Consort Medical has made 1 acquisition, including Aesica.
Consort Medical has 1 investor. Key investors include Recipharm.
Consort Medical operates through Consort Medical Limited.
Yes. Consort Medical was acquired by Recipharm in November 2019.

